Alzheimer's Drug Donanemab

An experimental Alzheimer’s drug, donanemab, was endorsed by a U.S. Food and Drug Administration advisory panel. The drug is designed to treat symptoms of early Alzheimer’s disease and has shown promising results in clinical trials.

Benefits of Eating Pomegranates for Alzheimer’s Patients

Eating pomegranates, strawberries, and walnuts containing urolithin A could help improve memory among Alzheimer’s patients, according to research. Urolithin A removes weak mitochondria from the brain, restoring cognitive function. Clinical trials are planned for humans.